Panc-1 Cells

PANC-1 cells, originating from a pancreatic duct carcinoma in a 56-year-old Caucasian male, stand as a pivotal epithelial cell line in the realm of cancer research, particularly in the study of pancreatic carcinoma. Panc1 cells offer a useful model for delving into the intricacies of pancreatic cancer, including ductal adenocarcinoma cell lines and their tumorigenic potential.
The cells’ epithelial morphology and their capacity to exhibit diverse morphological patterns underscore their relevance in mimicking the clonal heterogeneity and complex tumor microenvironment seen in pancreatic ductal adenocarcinoma (PDAC).
PANC-1 cells express markers such as vimentin and somatostatin receptors like SSTR2, which play a crucial role in neuroendocrine differentiation. This expression profile, coupled with the cells’ ability to undergo epithelial-mesenchymal transition (EMT) marker expression and EMT subtype shifting, makes them an excellent platform for exploring therapeutic strategies targeting the EMT process and neuroendocrine features of pancreatic cancer.
The cell line’s karyotypic analysis reveals a hyperdiploid state with notable genetic alterations, including the loss of the Y chromosome and mutations in critical genes such as CDKN2A and the p53 gene.
In summary, PANC-1 cells provide a multifaceted model for pancreatic cancer research, enabling detailed investigations into the phenotype and genotype of pancreatic adenocarcinoma, the efficacy of targeted therapies, and the molecular mechanisms driving cancer progression.